Blackstone Life Sciences

Blackstone Life Sciences (BXLS) is a private equity segment of The Blackstone Group. We combine scale capital with deep clinical development expertise to help advance innovative medicines and technologies with the potential to transform patients’ lives. Our team invests across the life cycle of companies and products in a range of therapeutic areas. We partner with pharmaceutical, biotech, and medical technology companies to fund products that address unmet medical needs and have the potential to improve the quality of life for patients around the world. BXLS combines clinical, commercial, and operational expertise with Blackstone’s knowledge and global network, access to capital, resources, and infrastructure. We commit our skill and scale to select, fund, and advance what we believe to be the most promising life science products and companies through hands-on involvement and directly applied expertise.